GSK plc

Common Name
GSK
Country
United Kingdom
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
68,629
Ticker
GSK
Exchange
LONDON STOCK EXCHANGE
Description
GSK plc is a leading global healthcare company that researches, develops, and manufactures innovative pharmaceutical and consumer healthcare products. This company primarily focuses on creating vaccin...

GSK's GHG Emissions Data Preview

In 2024, GSK completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, GSK has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download GSK's GHG Emissions data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind GSK’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore GSK’s data sources below and access millions more through our Disclosure Search.

a. GSK's Responsible Business Report 2024
Trace every data point back to GSK’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

b. GSK's ESG Report 2023
Trace every data point back to GSK’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into GSK's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of GSK amounted to 755,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of GSK decreased by 8.04%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

GSK's Scope 1 Emissions Over Time

202020212022202320240200 k400 k600 k800 ktCO2e-11%-1%-7%-10%
  • Total Scope 1
  • Year-over-Year Change

What are GSK's Scope 1 emissions?

In 2024, the total Scope 1 emissions of GSK were 521,000 metric tons of CO₂ equivalent (tCO₂e). a

Has GSK reduced its Scope 1 emissions over time?

Since 2020, GSK's Scope 1 emissions have decreased by 26.72%, reflecting a declining long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2023), GSK's Scope 1 emissions decreased by 10.33%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are GSK's Scope 2 emissions?

In 2024, GSK reported Scope 2 greenhouse gas (GHG) emissions of 44,000 tCO₂e using the market-based method and 234,000 tCO₂e using the location-based method. a

Has GSK reduced its Scope 2 emissions over time?

Since 2020, GSK's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 24.27%, reflecting a declining long-term trend in Scope 2 emissions over time. a b

Compared to the previous year (2023), GSK's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that GSK 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does GSK use for Scope 2 reporting?

In 2024, GSK reported its Scope 2 emissions using the market-based method and using the location-based method. a

GSK's Scope 2 Emissions Over Time

20202021202220232024080 k160 k240 k320 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based
Want Full Access to GSK's GHG Emissions Dataset?
Sign Up